Alseres Pharmaceuticals Buy Hold or Sell Recommendation

ALSEDelisted Stock  USD 0.01  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Alseres Pharmaceuticals is 'Not Rated'. Macroaxis provides Alseres Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALSE positions. The advice algorithm takes into account all of Alseres Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Alseres Pharmaceuticals' buy or sell advice are summarized below:
Real Value
0.0085
Hype Value
0.01
Market Value
0.01
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Alseres Pharmaceuticals given historical horizon and risk tolerance towards Alseres Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Alseres Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
In addition, we conduct extensive research on individual companies such as Alseres and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Alseres Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Execute Alseres Pharmaceuticals Buy or Sell Advice

The Alseres recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Alseres Pharmaceuticals. Macroaxis does not own or have any residual interests in Alseres Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Alseres Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Alseres PharmaceuticalsBuy Alseres Pharmaceuticals
Not Rated
For the selected time horizon Alseres Pharmaceuticals has a Return On Asset of -2.47, Profit Margin of (1.64) %, Operating Margin of (1.78) %, Current Valuation of 8.62 M, Shares Outstanding of 6.13 K and Price To Sales of 0.84 X
We provide trade advice to complement the prevailing expert consensus on Alseres Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Alseres Pharmaceuticals is not overpriced, please confirm all Alseres Pharmaceuticals fundamentals, including its cash and equivalents and the relationship between the cash flow from operations and current liabilities . As Alseres Pharmaceuticals appears to be a penny stock we also recommend to validate its revenue numbers.

Alseres Pharmaceuticals Trading Alerts and Improvement Suggestions

Alseres Pharmaceuticals is not yet fully synchronised with the market data
Alseres Pharmaceuticals has some characteristics of a very speculative penny stock
Alseres Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company currently holds 7.82 M in liabilities. Alseres Pharmaceuticals has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Alseres Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Alseres Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alseres Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alseres to invest in growth at high rates of return. When we think about Alseres Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 473.73 K. Net Loss for the year was (941.53 K) with profit before overhead, payroll, taxes, and interest of 450.04 K.
Alseres Pharmaceuticals currently holds about 186.95 K in cash with (1.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Alseres Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Alseres . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Alseres Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Alseres Pharmaceuticals? Buying financial instruments such as Alseres Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Alseres Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wholesale Thematic Idea Now

Wholesale
Wholesale Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in Alseres Pink Sheet

If you are still planning to invest in Alseres Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alseres Pharmaceuticals' history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites